This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
It is becoming increasingly complex to comply with pharmaceutical regulations around the world, with 80 percent of countries working to implement serialization as part of their strategy to fight counterfeit drugs and fraud.
The US, Brazil, EU, Russia, Bahrain, China, South Korea and others have specific serialization requirements when selling drugs in these regions, with more countries set to follow. Meeting regulatory requirements on the serialization of drugs is critical to ensure patients' safety and stay competitive. This requires a comprehensive suite of technology solutions, data gathering and communication with national track and trace systems that can exchange data quickly and securely.
This webinar will demystify many critical areas you need to consider for current and upcoming regulations in the EU, the US, Brazil and directives from other regulatory bodies such as the UAE, Russia and China.
Join this webinar to find out:
- What best practices organizations should implement for regulatory compliance for serialization
- Marketplace trends and track and trace needs to ensure supply chain visibility
- Which technologies can help you achieve full regulatory compliance
- What your readiness level is for the Drug Quality and Security Act (DSCSA) that comes into force in 2023
Speakers
Upender Solanki
Managing Director, Americas
Mark Highhouse
Sr. Accounts Director